![]() |
|
|
Vol. 295, Issue 3, 1249-1257, December 2000
Department of Physiology, University of Western Ontario, London,
Ontario, Canada
The role of protein kinase C (PKC) in lipopolysaccharide (LPS)- and
phorbol ester-induced changes in rat colonic cellular integrity and
Ca2+-independent inducible nitric-oxide synthase (iNOS)
activity was investigated. LPS treatment (3 mg kg
1 i.p.)
increased colonic cellular PKC activity within 1 h after administration. The percentage of nonviable cells and iNOS activity in
response to LPS were reduced by pretreatment with the selective PKC
antagonist GF 109203X (25 ng kg
1 i.v.). Pretreatment with
the selective iNOS inhibitor 1400W (5 mg kg
1 s.c.)
reduced the extent of cellular injury and iNOS activity but did not
affect the increase in LPS-mediated PKC activation. Reduction of
circulating neutrophils with anti-neutrophil serum reduced cell damage
as well as the increases in PKC and iNOS activities in response to LPS.
Intracolonic administration of the phorbol ester
phorbol-12-myristate-13-acetate (PMA; 3 mg kg
1) increased
colonic cellular PKC activity within 2 h after instillation. Cellular iNOS activity did not increase until 6 h after PMA
administration. The colonic responses to PMA were eliminated by GF
109203X. The selective iNOS inhibitor 1400W reduced the increase in
cell injury but did not affect the PKC activation in response to PMA.
LPS treatment also increased in the proteins for PKC-
, PKC-
,
PKC-
, and PKC-
. PMA treatment resulted in PKC-
and PKC-
translocation from cytosol to membrane. These data suggest that PKC
mediates iNOS activation and subsequent colonic cell injury in response to LPS administration. The
- and
-isozymes appear to be most closely associated with these responses.